Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Polyrizon said it has completed contracting for the fourth and fifth U.S. clinical sites for NASARIX™ first-in-human allergy study, completing all five U.S. site contracts for the trial.
Polyrizon (PLRZ) has completed all five U.S. site contracts for its NASARIX first-in-human allergy study.